Tobira Therapeutics Inc. (TBRA) Vaulted To A New High After Bought By Allergan

Tobira Therapeutics Inc. (TBRA) announced Tuesday morning that it has agreed to be acquired by Allergan (AGN) for an upfront payment of $28.35 per share in cash and up to $49.84 per share in Contingent Value Rights.

from RTT - Before the Bell http://ift.tt/2d84O2g
via IFTTT